Methylphenidate Hydrochloride extended-release tablets USP are indicated for the treatment of Attention Deficit Hyperactivity Disorder in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies ]. Methylphenidate, sold under the trade name Ritalin among others, is a stimulant...